|
Mr. Classon became Chairman of the Board of the Company on March 20 2006. He served as Interim President and Chief Executive Officer of the Company from May 11 2005 until March 20 2006 and as Vice Chairman of the Board from December 4 2003 until his election as Interim President and Chief Executive Officer. He was Chairman of the Executive Committee of Bayer HealthCare a sub group of Bayer AG from October 2002 to July 2004 and was President of Bayer Health Care L.L.C. a subsidiary of Bayer AG from October 2002 to July 2004. Previously he had been President of Bayer’s Diagnostic Division and head of Bayer’s Worldwide Business Group Diagnostics since 1995. Bayer is an international research-based company active in life sciences polymers and chemicals. A native of Sweden Mr. Classon joined Bayer’s Miles Diagnostics business in 1991 as Executive Vice President worldwide marketing sales and service. During his career Mr. Classon has held management positions with Pharmacia AB Sweden; Swedish Match Group; and Asbjorn Habberstad AB. Prior to joining Bayer he was President and Chief Operating officer of Pharmacia Biosystems AB. Mr. Classon currently serves on the Boards of Directors of Enzon Pharmaceuticals Inc. a company focused on oncology and antivirus pharmaceuticals ISTA Pharmaceuticals Inc. a company involved in opthamological pharmaceuticals Millipore Corporation a bioscience company that provides technologies tools and services for the discovery development and production of therapeutic drugs and for other purposes PharmaNet Development Group Inc. an international drug development services company and Auxilium Pharmaceuticals Inc. a specialty pharmaceutical company in the fields of urology and mens’ health. | 